These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 34116704
1. The LINC00922 aggravates ovarian cancer progression via sponging miR-361-3p. Wang L, Ren C, Xu Y, Yang L, Chen Y, Zhu Y. J Ovarian Res; 2021 Jun 11; 14(1):77. PubMed ID: 34116704 [Abstract] [Full Text] [Related]
10. Glycogen phosphorylase B promotes ovarian cancer progression via Wnt/β-catenin signaling and is regulated by miR-133a-3p. Zhou Y, Jin Z, Wang C. Biomed Pharmacother; 2019 Dec 11; 120():109449. PubMed ID: 31627092 [Abstract] [Full Text] [Related]
11. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5. Ye Z, He Q, Wang Q, Lin Y, Cen K, Chen X. Mol Cell Biochem; 2021 Oct 11; 476(10):3757-3769. PubMed ID: 34097192 [Abstract] [Full Text] [Related]
12. Knockdown of lncRNA HCG11 suppresses cell progression in ovarian cancer by modulating miR-144-3p/PBX3. Li XF, Hu DM, Zhao YX, Zhang L, Jin Y. Eur Rev Med Pharmacol Sci; 2020 Nov 11; 24(21):11032-11040. PubMed ID: 33215418 [Abstract] [Full Text] [Related]
13. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer. Xu H, Mao HL, Zhao XR, Li Y, Liu PS. J Ovarian Res; 2020 Mar 19; 13(1):31. PubMed ID: 32192508 [Abstract] [Full Text] [Related]
14. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells. Wang L, He M, Fu L, Jin Y. Exp Cell Res; 2020 Sep 01; 394(1):112129. PubMed ID: 32511950 [Abstract] [Full Text] [Related]
15. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression. Qiao ZW, Jiang Y, Wang L, Wang L, Jiang J, Zhang JR, Mu P. BMC Cancer; 2021 Sep 08; 21(1):1004. PubMed ID: 34496800 [Abstract] [Full Text] [Related]
16. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1. Dai T, Liang J, Liu W, Zou Y, Niu F, Li M, Zhang H, Li C, Fan M, Cui G. Bioengineered; 2021 Dec 08; 12(2):10771-10781. PubMed ID: 34793263 [Abstract] [Full Text] [Related]
17. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis. Gu H, Lin R, Zheng F, Zhang Q. J Mol Histol; 2021 Feb 08; 52(1):31-44. PubMed ID: 33099720 [Abstract] [Full Text] [Related]
18. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y, Dun Y, Zhou S, Huang XH. Biomed Pharmacother; 2017 Dec 08; 96():1216-1221. PubMed ID: 29239819 [Abstract] [Full Text] [Related]
19. LncRNA FGD5-AS1 promotes tumor growth by regulating MCL1 via sponging miR-153-3p in oral cancer. Ge C, Dong J, Chu Y, Cao S, Zhang J, Wei J. Aging (Albany NY); 2020 Jul 16; 12(14):14355-14364. PubMed ID: 32675387 [Abstract] [Full Text] [Related]
20. Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer. Yang Q, Yu Y, Sun Z, Pan Y. Biomed Pharmacother; 2018 Oct 16; 106():61-67. PubMed ID: 29957467 [Abstract] [Full Text] [Related] Page: [Next] [New Search]